A detailed history of Truist Financial Corp transactions in Dexcom Inc stock. As of the latest transaction made, Truist Financial Corp holds 161,531 shares of DXCM stock, worth $14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
161,531
Previous 167,318 3.46%
Holding current value
$14 Million
Previous $11.2 Million 12.03%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

SELL
$65.68 - $81.01 $380,090 - $468,804
-5,787 Reduced 3.46%
161,531 $12.6 Million
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $7.92 Million - $14.4 Million
123,822 Added 284.67%
167,318 $11.2 Million
Q2 2024

Aug 20, 2024

SELL
$110.31 - $140.45 $911,270 - $1.16 Million
-8,261 Reduced 15.96%
43,496 $4.93 Million
Q1 2024

May 10, 2024

SELL
$114.22 - $140.1 $27,412 - $33,624
-240 Reduced 0.46%
51,757 $7.18 Million
Q4 2023

Feb 02, 2024

SELL
$75.49 - $124.16 $1.82 Million - $2.99 Million
-24,088 Reduced 31.66%
51,997 $6.45 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $456,634 - $731,856
-5,306 Reduced 6.52%
76,085 $7.1 Million
Q2 2023

Aug 01, 2023

SELL
$112.47 - $130.98 $703,837 - $819,672
-6,258 Reduced 7.14%
81,391 $10.5 Million
Q1 2023

May 05, 2023

SELL
$104.0 - $122.92 $2.12 Million - $2.51 Million
-20,384 Reduced 18.87%
87,649 $10.2 Million
Q4 2022

Feb 17, 2023

SELL
$84.98 - $122.67 $595,199 - $859,180
-7,004 Reduced 6.09%
108,033 $12.2 Million
Q3 2022

Oct 26, 2022

BUY
$76.35 - $94.18 $215,077 - $265,305
2,817 Added 2.51%
115,037 $9.27 Million
Q2 2022

Jul 22, 2022

BUY
$67.99 - $132.89 $5.7 Million - $11.1 Million
83,876 Added 295.92%
112,220 $8.36 Million
Q1 2022

Apr 22, 2022

BUY
$94.08 - $130.2 $464,755 - $643,188
4,940 Added 21.11%
28,344 $14.5 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $59,350 - $74,408
457 Added 1.99%
23,404 $12.6 Million
Q3 2021

Nov 05, 2021

BUY
$106.71 - $143.18 $34,680 - $46,533
325 Added 1.44%
22,947 $12.5 Million
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $12,472 - $16,621
-154 Reduced 0.68%
22,622 $9.66 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $241,821 - $298,718
2,852 Added 14.31%
22,776 $8.19 Million
Q4 2020

Nov 19, 2021

SELL
$78.0 - $104.5 $1.46 Million - $1.96 Million
-18,780 Reduced 48.52%
19,924 $7.37 Million
Q4 2020

Feb 18, 2021

BUY
$78.0 - $104.5 $1.51 Million - $2.03 Million
19,397 Added 100.47%
38,704 $14.3 Million
Q3 2020

Nov 05, 2021

SELL
$95.51 - $112.95 $1.79 Million - $2.12 Million
-18,786 Reduced 49.32%
19,307 $7.96 Million
Q3 2020

Nov 13, 2020

BUY
$95.51 - $112.95 $3.63 Million - $4.3 Million
38,039 Added 70442.59%
38,093 $15.7 Million
Q2 2020

Nov 16, 2021

SELL
$62.68 - $105.34 $2.07 Million - $3.48 Million
-33,006 Reduced 99.84%
54 $22,000
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $978,184 - $1.64 Million
15,606 Added 89.41%
33,060 $13.4 Million
Q1 2020

Nov 05, 2021

SELL
$47.79 - $75.63 $1.31 Million - $2.07 Million
-27,396 Reduced 61.08%
17,454 $4.7 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $1.37 Million - $2.17 Million
28,643 Added 176.73%
44,850 $12.1 Million
Q4 2019

Nov 16, 2021

SELL
$36.62 - $57.29 $1.11 Million - $1.74 Million
-30,436 Reduced 65.25%
16,207 $3.55 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $1.71 Million - $2.67 Million
46,643 New
46,643 $10.2 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.